These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations? Zakarija A; Bennett CL Arch Intern Med; 2005 Apr; 165(7):722-3. PubMed ID: 15824289 [No Abstract] [Full Text] [Related]
6. Clinical uses for low-molecular-weight heparins. Wise GR West J Med; 1996 May; 164(5):440. PubMed ID: 8686303 [No Abstract] [Full Text] [Related]
11. [Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins]. Lobato-Mendizábal E; Majluf-Cruz A Rev Invest Clin; 2000; 52(5):529-45. PubMed ID: 11195182 [TBL] [Abstract][Full Text] [Related]
12. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins]. Delsart D; Chambefort V; Decousus H Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082 [No Abstract] [Full Text] [Related]
13. [Low molecular weight heparins: mechanisms of action and pharmococynetics. Clinical advantages over the classic unfractioned heparins]. Campos M Rev Port Cir Cardiotorac Vasc; 2003; 10(2):61-7. PubMed ID: 15094887 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of the low-molecular-weight heparins. Fareed J; Hoppensteadt DA Semin Thromb Hemost; 1996; 22 Suppl 2():13-8. PubMed ID: 8946614 [No Abstract] [Full Text] [Related]
15. [Low-molecular-weight heparin. Prophylaxis and treatment of thromboembolisms in surgery and obstetrics]. Nikolov A; Kovachev I; Petkov Iu; Dimitrov A Akush Ginekol (Sofiia); 2000; 39(3):35-40. PubMed ID: 11187995 [No Abstract] [Full Text] [Related]
16. Pathophysiology of thromboembolism and its modulation by low molecular weight heparins. Breddin HK Semin Thromb Hemost; 1993; 19 Suppl 1():227-8. PubMed ID: 8395726 [No Abstract] [Full Text] [Related]